Literature DB >> 19110621

Retroviral transduction of murine primary T lymphocytes.

James Lee1, Michel Sadelain, Renier Brentjens.   

Abstract

In comparison to human T cells, efficient retroviral gene transfer and subsequent expansion of murine primary T cells is more difficult to achieve. Herein, we describe an optimized gene transfer protocol utilizing an ecotropic viral vector to transduce primary murine T cells activated with magnetic beads coated with agonistic anti-CD3 and CD28 antibodies. Activated T cells are subsequently centrifuged (spinoculated) on RetroNectin-coated tissue culture plates in the context of retroviral supernatant. Variables found to be critical to high gene transfer and subsequent efficient T cell expansion included CD3/CD28 magnetic bead to cell ratio, time from T cell activation to initial spinoculation, frequency of T cell spin-oculation, interleukin-2 concentration in the medium, and the initial purity of the T cell preparation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19110621      PMCID: PMC5003426          DOI: 10.1007/978-1-59745-409-4_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

2.  Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter.

Authors:  H Wang; M P Kavanaugh; R A North; D Kabat
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

3.  Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.

Authors:  A B Hagani; I Rivière; C Tan; A Krause; M Sadelain
Journal:  J Gene Med       Date:  1999 Sep-Oct       Impact factor: 4.565

4.  High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.

Authors:  K E Pollok; H Hanenberg; T W Noblitt; W L Schroeder; I Kato; D Emanuel; D A Williams
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Successful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency.

Authors:  M Onodera; T Ariga; N Kawamura; I Kobayashi; M Ohtsu; M Yamada; A Tame; H Furuta; M Okano; S Matsumoto; H Kotani; G J McGarrity; R M Blaese; Y Sakiyama
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

Review 6.  Genetically modified immunocompetent cells in HIV infection.

Authors:  G Palù; G Li Pira; F Gennari; D Fenoglio; C Parolin; F Manca
Journal:  Gene Ther       Date:  2001-11       Impact factor: 5.250

7.  Mechanisms of DNA uptake by mammalian cells: fate of exogenously added DNA monitored by the use of fluorescent dyes.

Authors:  A Loyter; G A Scangos; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

Authors:  Renier J Brentjens; Jean-Baptiste Latouche; Elmer Santos; Francesc Marti; Michael C Gong; Clay Lyddane; Philip D King; Steven Larson; Mark Weiss; Isabelle Rivière; Michel Sadelain
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

Review 9.  Application of cellular gene therapy for rheumatoid arthritis.

Authors:  Atsuo Nakajima
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

10.  Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.

Authors:  I Rivière; K Brose; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

View more
  21 in total

1.  PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.

Authors:  Evgeni Efimenko; Utpal P Davé; Irina V Lebedeva; Yao Shen; Maria J Sanchez-Quintero; Daniel Diolaiti; Andrew Kung; Brian J Lannutti; Jianchung Chen; Ronald Realubit; Zoya Niatsetskaya; Vadim Ten; Charles Karan; Xi Chen; Andrea Califano; Thomas G Diacovo
Journal:  Mol Cancer Ther       Date:  2017-07-17       Impact factor: 6.261

2.  Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.

Authors:  Arnab Ghosh; Melody Smith; Scott E James; Marco L Davila; Enrico Velardi; Kimon V Argyropoulos; Gertrude Gunset; Fabiana Perna; Fabiana M Kreines; Emily R Levy; Sophie Lieberman; Hillary V Jay; Andrea Z Tuckett; Johannes L Zakrzewski; Lisa Tan; Lauren F Young; Kate Takvorian; Jarrod A Dudakov; Robert R Jenq; Alan M Hanash; Ana Carolina F Motta; George F Murphy; Chen Liu; Andrea Schietinger; Michel Sadelain; Marcel R M van den Brink
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

3.  Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.

Authors:  Verena Staedtke; Ren-Yuan Bai; Kibem Kim; Martin Darvas; Marco L Davila; Gregory J Riggins; Paul B Rothman; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Nature       Date:  2018-12-12       Impact factor: 49.962

4.  Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.

Authors:  Hollie J Pegram; James C Lee; Erik G Hayman; Gavin H Imperato; Thomas F Tedder; Michel Sadelain; Renier J Brentjens
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

5.  Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.

Authors:  Daniel Hirschhorn-Cymerman; Sadna Budhu; Shigehisa Kitano; Cailian Liu; Feng Zhao; Hong Zhong; Alexander M Lesokhin; Francesca Avogadri-Connors; Jianda Yuan; Yanyun Li; Alan N Houghton; Taha Merghoub; Jedd D Wolchok
Journal:  J Exp Med       Date:  2012-09-24       Impact factor: 14.307

Review 6.  Novel immunotherapies in lymphoid malignancies.

Authors:  Connie Lee Batlevi; Eri Matsuki; Renier J Brentjens; Anas Younes
Journal:  Nat Rev Clin Oncol       Date:  2015-11-03       Impact factor: 66.675

7.  Aberrant tissue localization of fungus-specific CD4+ T cells in IL-10-deficient mice.

Authors:  Amariliz Rivera; Nichole Collins; Matthias T Stephan; Lauren Lipuma; Ingrid Leiner; Eric G Pamer
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

8.  A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.

Authors:  Ranjan Upadhyay; Jonathan A Boiarsky; Gvantsa Pantsulaia; Judit Svensson-Arvelund; Matthew J Lin; Aleksandra Wroblewska; Sherry Bhalla; Nathalie Scholler; Adrian Bot; John M Rossi; Norah Sadek; Samir Parekh; Alessandro Lagana; Alessia Baccarini; Miriam Merad; Brian D Brown; Joshua D Brody
Journal:  Cancer Discov       Date:  2020-12-17       Impact factor: 39.397

9.  Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells.

Authors:  Dinali Wijewarnasuriya; Christina Bebernitz; Andrea V Lopez; Sarwish Rafiq; Renier J Brentjens
Journal:  Cancer Immunol Res       Date:  2020-03-25       Impact factor: 11.151

10.  Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.

Authors:  Koen Debackere; Lukas Marcelis; Sofie Demeyer; Marlies Vanden Bempt; Nicole Mentens; Olga Gielen; Kris Jacobs; Michael Broux; Gregor Verhoef; Lucienne Michaux; Carlos Graux; Iwona Wlodarska; Philippe Gaulard; Laurence de Leval; Thomas Tousseyn; Jan Cools; Daan Dierickx
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.